New policies promise to spur pediatric drug development, dosing information.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 700
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 1998 AND VI 33 AND IP 7
Results: 21
1
2
Cost consequences from switching from one diltiazem formulation to another.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 698
- Publication type:
- Article
3
Class review of statins results in formulary changes.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 697
- Publication type:
- Article
4
Surgical prophylaxis protocol improves quality of care, decreases antibiotic costs.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 697
- Publication type:
- Article
5
American Society of Clinical Oncology's 34th annual meeting.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 688
- Publication type:
- Article
6
The Academy of Managed Care Pharmacy's 10th annual meeting.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 679
- Publication type:
- Article
7
New approaches to the development and use of treatment guidelines.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 665
- By:
- Publication type:
- Article
8
Factors in the development and maintenance of a rational antibiotic formulary.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 659
- By:
- Publication type:
- Article
9
Determining the cost of antimicrobial therapy: A focus on fluoroquinolones.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 648
- By:
- Publication type:
- Article
10
Focus on eptifibatide: GP IIb/IIIa inhibitor reduces complications of angioplasty, acute coronary syndrome.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 632
- By:
- Publication type:
- Article
11
Direct-to-consumer (DTC) advertising more than triples in 2 years, Scott-Levin reports.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 630
- Publication type:
- Article
12
Formulary exceptions policy required in NCQA draft standards.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 630
- Publication type:
- Article
13
Fluvastatin shown for first time to reduce cardiac events in patients with symptomatic CHD.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 630
- Publication type:
- Article
14
Expert panel issues drug guidelines for agitation in elderly dementia patients.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 629
- Publication type:
- Article
15
Pipeline preview.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 610
- Publication type:
- Article
16
Inappropriate dosing, other shortcomings widespread in schizophrenia drug therapy.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 625
- Publication type:
- Article
17
Survey finds HMOs, PBMs still moving to restricted formularies, quickly advancing in informatics.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 622
- Publication type:
- Article
18
New indications.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 621
- Publication type:
- Article
19
New molecular entities.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 610
- Publication type:
- Article
20
Single-isomer version of albuterol promises more potent bronchodilation.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 626
- Publication type:
- Article
21
Formulary scorecard.
- Published in:
- Formulary, 1998, v. 33, n. 7, p. 609
- Publication type:
- Article